These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2157122)

  • 21. Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites.
    Itzhak Y
    Life Sci; 1988; 42(7):745-52. PubMed ID: 2893238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of opioid receptors in cultured neurons.
    Vaysse PJ; Zukin RS; Fields KL; Kessler JA
    J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
    Holtzman SG
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1054-62. PubMed ID: 2539453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for an endogenous peptide ligand for the phencyclidine receptor.
    Quirion R; DiMaggio DA; French ED; Contreras PC; Shiloach J; Pert CB; Everist H; Pert A; O'Donohue TL
    Peptides; 1984; 5(5):967-73. PubMed ID: 6095223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
    J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing stereospecificities distinguish opiate receptor subtypes.
    Zukin SR
    Life Sci; 1982 Sep 20-27; 31(12-13):1307-10. PubMed ID: 6292619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla.
    Rogers C; Cécyre D; Lemaire S
    Biochem Pharmacol; 1989 Aug; 38(15):2467-72. PubMed ID: 2547382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
    Contreras PC; Quirion R; O'Donohue TL
    NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative stimulus properties of stereoisomers of cyclazocine in phencyclidine-trained squirrel monkeys.
    Brady KT; Balster RL
    Life Sci; 1982 Aug; 31(6):541-9. PubMed ID: 6290818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding.
    Johnson KM; Snell LD
    Pharmacol Biochem Behav; 1985 May; 22(5):731-5. PubMed ID: 2989942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
    Zukin SR; Brady KT; Slifer BL; Balster RL
    Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.
    Churchill L; Dilts RP; Kalivas PW
    Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA receptor antagonist effects of the stereoisomers of beta-cyclazocine in rats, in vivo and in vitro.
    Church J; Millar JD; Jones MG; Lodge D
    Eur J Pharmacol; 1991 Jan; 192(3):337-42. PubMed ID: 1647315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.